These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia. Furukawa Y; Kapatos G; Haycock JW; Worsley J; Wong H; Kish SJ; Nygaard TG Ann Neurol; 2002 May; 51(5):637-41. PubMed ID: 12112113 [TBL] [Abstract][Full Text] [Related]
24. Dopa-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations. Furukawa Y; Graf WD; Wong H; Shimadzu M; Kish SJ Neurology; 2001 Jan; 56(2):260-3. PubMed ID: 11160968 [TBL] [Abstract][Full Text] [Related]
25. Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus, DYT14. Grötzsch H; Pizzolato GP; Ghika J; Schorderet D; Vingerhoets FJ; Landis T; Burkhard PR Neurology; 2002 Jun; 58(12):1839-42. PubMed ID: 12084887 [TBL] [Abstract][Full Text] [Related]
26. Cases of dopa-responsive dystonia (Segawa disease) in Estonia. Talvik I; Segawa M; Veri K; Gross-Paju K; Talvik T Brain Dev; 2010 May; 32(5):428-31. PubMed ID: 19427147 [TBL] [Abstract][Full Text] [Related]
27. [Bromocriptine and L-dopa therapy: comparison in a case of hereditary progressive dystonia with marked diurnal fluctuations]. Nomura K; Yamamoto N; Takahashi I; Furune S; Aso K; Negoro T; Watanabe K No To Hattatsu; 1987 May; 19(3):244-8. PubMed ID: 3580205 [No Abstract] [Full Text] [Related]
28. Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis. Nygaard TG Adv Neurol; 1993; 60():577-85. PubMed ID: 8420194 [No Abstract] [Full Text] [Related]
39. Dopa-responsive dystonia: a widening spectrum. Gordon N Dev Med Child Neurol; 1996 Jun; 38(6):554-9. PubMed ID: 8647336 [No Abstract] [Full Text] [Related]